Nat Padhiar

TL;DR: HVIGI significantly reduces pain and improves function in patients with resistant Achilles tendinopathy in the short- and long-term.

TL;DR: Current ICP pressure criteria for CECS diagnosis are therefore unreliable, and emphasis should remain on good history, and clinicians may consider measurements taken at 1 minute after exercise because mean levels at this timing interval only did not overlap between subjects and controls in the studies the authors analyzed.

TL;DR: HVIGI for resistant tendinopathy of the main body of the Achilles tendon is effective to improve symptoms, reduce neovascularisation, and decrease maximal tendon thickness at short-term follow-up.

TL;DR: High volume injections to mechanically disrupt the neovascularisation in patellar tendinopathy are helpful in the management of this condition and controlled trials would be warranted to investigate this management modality.

TL;DR: There is agreement among orthopedic surgeons on the role of ICPs for diagnosis and the choice of fasciotomy as a first-line surgical procedure, but there is a divergence of opinions regarding the ICP diagnostic thresholds, the roles of conservative management and the surgical techniques for fAsciotomy and failure of decompression.